Clinical Trial

Acupuncture for Lung Cancer-Related Fatigue

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of acupuncture in alleviating cancer-related fatigue (CRF) among lung cancer survivors. It addresses the key issue of limited high-quality evidence for acupuncture's effect on CRF by rigorously comparing real acupuncture against a non-penetrating sham needle control in 120 eligible participants. Patients will be centrally randomized (1:1), blinded, and receive 12-session treatment over 4 weeks. Participants will complete treatment and attend follow-up visits up to week 16, and repeatedly complete fatigue (BFI-C, MFI-20), psychological (PHQ-9, GAD-7, FCRI), functional (CWSAS), and sleep (ISI) assessments.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-13.
Trial Details
NCT Number NCT07079072
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions Lung Cancer
Enrollment 120 participants
Start Date 2025-08-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-25